Valantine Hannah

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
8 38% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 245%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Valantine Hannah's trades of BridgeBio Pharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-12 2026-03-10
PlS Planned sale
82,113 -44.3%
190.57
US$897,388 		82,113 -44.3% 190.57 US$897,388
2026-03-10 2026-03-10
PrS Proposed sale
16,191
42.54
US$1,251,582 		16,191 42.54 US$1,251,582
2026-03-03 2026-02-27
PlS Planned sale
97,064 +39.6%
16.09
US$661,141 		97,064 +39.6% 16.09 US$661,141
2026-03-03 2026-02-27
PlS Planned sale
14,584 -44.3%
67.08
US$978,285 		14,584 -44.3% 67.08 US$978,285
2026-02-27 2026-02-27
PrS Proposed sale
25,484
67.41
US$1,717,780 		25,484 67.41 US$1,717,780
2025-11-14 2025-11-12
S Sale
25,484 -77.3%
66.07
US$1,683,728 		25,484 -77.3% 66.07 US$1,683,728
2025-11-12 2025-11-12
PrS Proposed sale
25,484
66.07
US$1,683,728 		25,484 66.07 US$1,683,728
2025-06-30 2025-06-26
S Sale
1,891 -82.6%
44.03
US$83,261 		1,891 -82.6% 44.03 US$83,261
2025-06-30 2025-06-26
S Sale
398 -14.8%
44.13
US$17,562 		398 -14.8% 44.13 US$17,562
2025-06-30 2025-06-26
S Sale
1,542 -17.1%
44.01
US$67,863 		1,542 -17.1% 44.01 US$67,863
2025-06-30 2025-06-26
S Sale
876 -8.9%
44.11
US$38,640 		876 -8.9% 44.11 US$38,640
2025-06-26 2025-06-26
PrS Proposed sale
1,891
44.03
US$83,261 		1,891 44.03 US$83,261
2025-06-26 2025-06-26
PrS Proposed sale
1,542
44.01
US$67,863 		1,542 44.01 US$67,863
2025-06-26 2025-06-26
PrS Proposed sale
876
44.11
US$38,640 		876 44.11 US$38,640
2025-06-26 2025-06-26
PrS Proposed sale
398
44.13
US$17,562 		398 44.13 US$17,562
2025-06-23 2025-06-18
US CareDx Inc (CDNA)
PlS Planned sale
10,570 -21.3%
19.16
US$202,566 		10,570 -21.3% 19.16 US$202,566
2025-06-18 2025-06-18
US CareDx Inc (CDNA)
PrS Proposed sale
10,570
19.52
US$206,326 		10,570 19.52 US$206,326
2025-06-11 2025-06-10
PlS Planned sale
4,292 -70.9%
40.00
US$171,680 		4,292 -70.9% 40.00 US$171,680
2025-06-10 2025-06-10
PrS Proposed sale
4,292
40.00
US$171,680 		4,292 40.00 US$171,680
2025-03-10 2025-03-06
PlS Planned sale
12,875 -87.9%
32.58
US$419,500 		12,875 -87.9% 32.58 US$419,500
2025-03-06 2025-03-06
PrS Proposed sale
12,875
32.58
US$419,500 		12,875 32.58 US$419,500
2024-02-20 2024-02-15
PlS Planned sale
2,915 -62.3%
37.75
US$110,041 		2,915 -62.3% 37.75 US$110,041
2024-02-15 2024-02-15
PrS Proposed sale
2,915
37.75
US$110,041 		2,915 37.75 US$110,041
2024-01-18 2024-01-16
PlS Planned sale
2,915 -62.3%
37.97
US$110,683 		2,915 -62.3% 37.97 US$110,683
2024-01-16 2024-01-16
PrS Proposed sale
2,915
37.97
US$110,683 		2,915 37.97 US$110,683
2023-12-19 2023-12-15
PlS Planned sale
2,915 -62.3%
36.12
US$105,290 		2,915 -62.3% 36.12 US$105,290
2023-12-15 2023-12-15
PrS Proposed sale
2,915
36.12
US$105,290 		2,915 36.12 US$105,290
2023-11-17 2023-11-15
PlS Planned sale
2,915 -62.3%
30.00
US$87,450 		2,915 -62.3% 30.00 US$87,450
2023-11-15 2023-11-15
PrS Proposed sale
2,915
30.00
US$87,450 		2,915 30.00 US$87,450
2022-01-03 2021-12-29
B Purchase
1,764 +inf%
14.23
US$25,102 		1,764 +inf% 14.23 US$25,102
2024-02-13 2021-12-28
B Purchase
1,542 +81.5%
12.68
US$19,553 		1,542 +81.5% 12.68 US$19,553
2024-02-13 2021-12-28
B Purchase
1,891 +inf%
13.18
US$24,923 		1,891 +inf% 13.18 US$24,923